Related Experiment Video
Updated: Mar 9, 2026

5-Ethynyl-2'-Deoxyuridine/Phospho-Histone H3 Dual-Labeling Protocol for Cell Cycle Progression Analysis in Drosophila Neural Stem Cells
Published on: May 4, 2021
UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular
Ting Zhang1, Linglin Zhao1, Shengyuan Zeng1
1Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, P.R. China.
Abstract:
Ubiquitin-like with PHD and ring finger domains 2 (UHRF2) is a multi-domain E3 ubiquitin ligase which is involved in epigenetic regulation and plays an essential role in tumorigenesis. However, the role of UHRF2 in histone H3 acetylation has not yet been fully elucidated and few studies have reported its role in hepatocellular carcinoma (HCC). In this study, we examined the correlation between UHRF2 and acetylated H3 in HCC. Immunohistochemistry and western blot analysis demonstrated that the levels of histone H3 lysine 9 acetylation (H3K9ac) and histone H3 lysine 14 acetylation (H3K14ac) were higher in the HCC tissues and HepG2 HCC cells compared with the adjacent non-tumor tissues and L02 normal cells. The level of UHRF2 was higher in the HCC tissues compared with the adjacent non-tumor tissues, but its expression did not exhibit a significant difference between the HepG2 HCC cells and the L02 normal cells. In addition, when comparing the HCC tissues, a higher expression of UHRF2 correlated with a lower expression of H3K9ac in the HCC tissues. The overexpression of UHRF2 increased the expression of H3K9ac in L02 normal cells (P<0.01), but decreased the expression of H3K9ac in HepG2 cancer cells (P<0.05). Moreover, immunofluorescence staining and co-immunoprecipitation assay indicated that UHRF2 co-localized and interacted with H3K9ac in L02 and HepG2 cells and the plant homeodomain (PHD) finger domain was the key domain for UHRF2 directly binding to H3K9ac. Taken together, these results suggest that UHRF2 decreases the expression of H3K9ac in HepG2 HCC cells and interacts with it through the PHD domain.
Insights
Ubiquitin-like with PHD and ring finger domains 2 (UHRF2) impacts histone acetylation in liver cancer. UHRF2 decreases H3K9ac in hepatocellular carcinoma cells, interacting via its PHD domain.
Area of Science:
- Epigenetics and molecular biology
- Cancer research
- Biochemistry
Background:
- Ubiquitin-like with PHD and ring finger domains 2 (UHRF2) is an E3 ubiquitin ligase involved in epigenetic regulation and tumorigenesis.
- The role of UHRF2 in histone acetylation, particularly in hepatocellular carcinoma (HCC), remains incompletely understood.
Purpose of the Study:
- To investigate the correlation between UHRF2 expression and histone H3 acetylation in HCC.
- To elucidate the functional interaction between UHRF2 and acetylated histone H3 in HCC cells.
Main Methods:
- Immunohistochemistry and western blot analysis to assess protein and acetylation levels.
- Immunofluorescence staining and co-immunoprecipitation assays to determine protein localization and interaction.
- Overexpression studies in normal and HCC cell lines.
Main Results:
- Higher levels of H3K9ac and H3K14ac were observed in HCC tissues and cells compared to normal tissues and cells.
- UHRF2 expression was elevated in HCC tissues, but not significantly different between HepG2 and L02 cells.
- UHRF2 overexpression decreased H3K9ac in HepG2 cells but increased it in L02 cells, indicating a context-dependent role.
- UHRF2 directly interacts with H3K9ac, with the PHD finger domain being crucial for this binding.
Conclusions:
- UHRF2 plays a complex role in regulating histone H3 acetylation in hepatocellular carcinoma.
- UHRF2 decreases H3K9ac expression in HepG2 HCC cells through direct interaction mediated by its PHD domain.
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Spreading of Chromatin Modifications
Writers
The writer...

